These results demonstrated that knockdown of PPP2R3A in liver cancer cells inhibited cell proliferation, led to an arrest in G1/S phase, and upregulated the expression of p53, which plays a major role in the G1/S checkpoint. This evidence concerns the gene TP53 and liver cancer.